Tell your doctor if you have ever been told you had Bipolar Disorder ("Manic Depression") or have had a "manic" or "psychotic" episode.
For more information, including full Prescribing Information, please visit http://www.prozac.com, or call 1-800-LillyRX.
Prozac(R) is a registered trademark of Eli Lilly and Company. Prozac(R)Weekly(TM) is a trademark of Eli Lilly and Company. Sarafem(R) is a registered trademark of Warner Chilcott, Inc.
Important Safety Information
Cymbalta is approved to treat major depressive disorder and generalized anxiety disorder and manage diabetic peripheral neuropathic pain. Antidepressants can increase suicidal thoughts and behaviors in children, adolescents and young adults. Patients should call their doctor right away if they experience new or worsening depression symptoms, unusual changes in behavior, or thoughts of suicide. Be especially observant within the first few months of treatment or after a change in dose. Cymbalta is approved only for adults 18 and over.
Cymbalta is not for everyone. Patients should not take Cymbalta if they
have recently taken a type of antidepressant called a monoamine oxidase
inhibitor (MAOI), are taking Mellaril(R) (thioridazine) or have
uncontrolled glaucoma. Patients should speak with their doctor about any
medical conditions they may have, including liver or kidney problems or
glaucoma. Patients should tell their doctor about all of their medicines,
including those for migraine to avoid a potentially life-threatening
condition, and NSAIDs
|SOURCE Eli Lilly and Company|
Copyright©2008 PR Newswire.
All rights reserved